Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap Phase 2a in Dry Eye Syndrome
NCT03162783Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in dry eye syndrome (DED), sponsored by Aldeyra Therapeutics. Started May 2017; status: completed.
02
Drugs
reproxalap
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03162783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03162783.